Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches
- PMID: 18381524
- DOI: 10.1542/peds.2007-1532
Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches
Abstract
Objective: The objective of this study was to investigate the growth of stimulant-naive children with attention-deficit/hyperactivity disorder in 3 aspects of development: level, trend, and structure of the process.
Patients and method: The study sample included 53 individuals between the ages of 6 and 17 years (mean: 11.90). The average level of growth (z scores) in prepubertal, pubertal, and postpubertal stage of development and trend of the process were estimated on the basis of a comparison with growth charts. The prediction of adolescent growth spurt was conducted using the mathematical structural growth model of Jolioceur, Pontier, and Abidi.
Results: Difference between boys with attention-deficit/hyperactivity and the norm was statistically significant in the prepubertal stage and for the average level of growth between the ages of 2 and 17 years. Distinct suppression of growth was found between the ages of 9 and 14. Analysis of development structure revealed an earlier onset of the adolescent growth spurt among boys (difference: 5 months) and a higher velocity of growth at this moment (difference: 0.33 cm/year) than expected values.
Conclusions: The application of both cross-sectional and longitudinal analyses clearly illustrated the higher level of growth of boys with attention-deficit/hyperactivity in the prepubertal stage, the suppression of growth on the turn of prepubertal and pubertal periods, and earlier occurrence of the spurt onset. Observed differences in the level and trend of growth as well as in the parameters of adolescent growth spurt are linked with disorder-related factors.
Comment in
-
Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.Pediatrics. 2008 Jul;122(1):221; author reply 221-2. doi: 10.1542/peds.2008-1083. Pediatrics. 2008. PMID: 18596017 No abstract available.
Similar articles
-
Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.Pediatrics. 2008 Jul;122(1):221; author reply 221-2. doi: 10.1542/peds.2008-1083. Pediatrics. 2008. PMID: 18596017 No abstract available.
-
Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.J Med Assoc Thai. 2011 Aug;94 Suppl 3:S158-63. J Med Assoc Thai. 2011. PMID: 22043770
-
Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.J Pediatr. 2008 Mar;152(3):394-9. doi: 10.1016/j.jpeds.2007.07.052. Epub 2007 Oct 24. J Pediatr. 2008. PMID: 18280848
-
Growth on stimulant medication; clarifying the confusion: a review.Arch Dis Child. 2005 Aug;90(8):801-6. doi: 10.1136/adc.2004.056952. Arch Dis Child. 2005. PMID: 16040876 Free PMC article. Review.
-
Effect of stimulants on height and weight: a review of the literature.J Am Acad Child Adolesc Psychiatry. 2008 Sep;47(9):994-1009. doi: 10.1097/CHI.ObO13e31817eOea7. J Am Acad Child Adolesc Psychiatry. 2008. PMID: 18580502 Review.
Cited by
-
Trajectories of growth and symptoms of attention-deficit/hyperactivity disorder in children: a longitudinal study.BMC Pediatr. 2011 Oct 10;11:84. doi: 10.1186/1471-2431-11-84. BMC Pediatr. 2011. PMID: 21985742 Free PMC article.
-
A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.J Am Acad Child Adolesc Psychiatry. 2020 Dec;59(12):1330-1341. doi: 10.1016/j.jaac.2019.08.472. Epub 2019 Aug 29. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 31473291 Free PMC article. Clinical Trial.
-
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.Drugs. 2010;70(1):15-40. doi: 10.2165/11530540-000000000-00000. Drugs. 2010. PMID: 20030423
-
ADHD, stimulant treatment, and growth: a longitudinal study.Pediatrics. 2014 Oct;134(4):e935-44. doi: 10.1542/peds.2014-0428. Epub 2014 Sep 1. Pediatrics. 2014. PMID: 25180281 Free PMC article.
-
European guidelines on managing adverse effects of medication for ADHD.Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3. Eur Child Adolesc Psychiatry. 2011. PMID: 21042924 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical